Skip to main content
Clinical Trials/NCT03005626
NCT03005626
Completed
Not Applicable

Transition From Adolescents to Adulthood for Patients With Congenital Patients With Congenital Heart Diseases: Impact of a Therapeutic Education Program on Quality of Life

University Hospital, Montpellier1 site in 1 country200 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Heart Diseases
Sponsor
University Hospital, Montpellier
Enrollment
200
Locations
1
Primary Endpoint
PedsQL 4.0 score
Status
Completed
Last Updated
last year

Overview

Brief Summary

The Investigators aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.

Detailed Description

The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously investigators decided to measure its impact. Indeed investigators need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, investigators chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes. The investigators assume that patients who participate in this program will improve their quality of life compared to controls. If investigators demonstrate the benefit of this program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
November 16, 2020
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient from 13 years to 25 years inclusive.
  • Carrying of Congenital Heart Disease as defined in the International Classification.
  • Possible follow-up for one year on one of the three hospital center.
  • Informed consent of the patient for adults and, parents or legal guardians for minors.
  • Affiliation to a social security system.

Exclusion Criteria

  • Non-francophone,
  • Severe intellectual impairment.

Outcomes

Primary Outcomes

PedsQL 4.0 score

Time Frame: Follow up of patients over 12 months

Evolution of the quality of life assessed by PedsQL 4.0 self-reported scores from month 0 to month 12.

Secondary Outcomes

  • Disease severity(Follow up of patients over 12 months)
  • Anxiety and depression(Follow up of patients over 12 months)
  • Ricci and Gagnon score(Follow up of patients over 12 months)
  • Leuven Knowledge score(Follow up of patients over 12 months)
  • Physiological parameters(Follow up of patients over 12 months)

Study Sites (1)

Loading locations...

Similar Trials